Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on August 8, 2019, reporting events that occurred on August 7, 2019. The filing details a private placement transaction involving the issuance of equity securities to institutional and accredited investors.
Key Financial Metrics and Transaction Details
The filing does not provide standard operating metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to the capital raise:
- Net Proceeds: Approximately $23.1 million (after offering expenses).
- Securities Issued:
- 6,585,000 shares of Common Stock at $2.05 per share.
- 5,610,121 shares of Series B Convertible Preferred Stock at $2.05 per share.
- Use of Proceeds: General corporate purposes.
- Placement Agent: Cowen and Company, LLC.
Material Changes and New Securities
The Company entered into a Securities Purchase Agreement and a Registration Rights Agreement. Key terms include:
- Conversion Rights: Series B Preferred Stock is convertible into Common Stock on a one-for-one basis, subject to adjustments for stock splits or combinations.
- Ownership Blocker: Conversion is blocked if the holder would exceed 9.99% beneficial ownership (adjustable with 61 days' notice).
- Voting Rights: Series B Preferred Stock is non-voting except as required by law.
- Dividends: Series B holders receive dividends on an as-if-converted basis simultaneously with Common Stock.
- Liquidation Preference: Pari passu with Common Stock, entitled to $0.001 per share plus unpaid dividends.
- Registration Obligations: The Company must file a resale registration statement within 45 days of closing and have it declared effective within 90 days of closing.
- Liquidated Damages: Failure to meet registration deadlines triggers a penalty of 1.0% of the aggregate purchase price, accruing interest at 1.0% per month.
- Verify the final closing date and confirmation of the $23.1 million net proceeds.
- Review the attached Certificate of Designation (Exhibit 3.1) for specific terms regarding the Series B Preferred Stock.
- Monitor the filing of the resale registration statement (S-1 or S-3) within the required 45-day window.
- Check subsequent filings for any dilution impact on existing shareholders due to the conversion of Series B Preferred Stock.
- Confirm the identity of the institutional buyers listed in the Schedule of Buyers attached to the Securities Purchase Agreement (Exhibit 10.1).
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclaimers regarding the agreements. The primary contingency noted is the potential financial penalty for failing to timely register the resale of the securities.